Research Topic · Peer-Reviewed

Adenocarcinoma Cells

Adenocarcinoma cells are malignant epithelial cells that originate from glandular tissue or from epithelia with secretory, gland-forming capacity. They typically retain features of their tissue of origin, organizing into gland-like or tubular structures and often producing mucin, which distinguishes them histologica…

Curated from this journal's research 📚 10 peer-reviewed articles cited Cited 35× across the literature 🔖 ISSN 2379-8572 🗓 Reviewed July 2026

Overview

Adenocarcinoma cells are malignant epithelial cells that originate from glandular tissue or from epithelia with secretory, gland-forming capacity. They typically retain features of their tissue of origin, organizing into gland-like or tubular structures and often producing mucin, which distinguishes them histologically from squamous and other carcinoma types. Adenocarcinomas arise in many organs that contain glandular epithelium, including the prostate, stomach, lung, breast, endometrium, and gastrointestinal tract, and their behavior ranges from well-differentiated, slow-growing tumors to poorly differentiated forms with high metastatic potential. Diagnosis relies on histopathology supported by immunohistochemical markers and, increasingly, molecular characterization, while functional imaging such as 18F-FDG PET/CT assists staging and detection. The biology of these cells includes dysregulated proliferation, evasion of programmed cell death, altered tissue and trace-element composition, and interactions with hormonal and growth-factor signaling that can drive progression in hormone-responsive sites such as the prostate and endometrium. Adenocarcinoma cell lines are widely used experimental models for studying tumor cell behavior, biomarker expression, and responses to candidate treatments. Because outcome depends heavily on grade, stage, and site, early detection and accurate classification of adenocarcinoma cells are central to oncologic management and to the development of targeted and conventional therapies.

Research published in this journal

10 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 10 articles above have been cited 35 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Adenocarcinoma Cells, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Otolaryngology Advances (ISSN 2379-8572).

Journal editorial board
Ioannis Chatzistefanou · Greece Heather Bortfeld · United States Heidi Silver · United States

This page summarises published research for orientation; it is not medical or professional advice.